ODI Pharma AB (publ) (FRA:6OD)

Germany flag Germany · Delayed Price · Currency is EUR
0.1720
+0.0040 (2.38%)
At close: Jun 26, 2026
Market Cap4.24M +12.8%
Revenue (ttm)2.72M +182.1%
Net Income-33.05K
EPS-0.00
Shares Out n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Open0.1720
Previous Close0.1680
Day's Range0.1720 - 0.1720
52-Week Range0.0625 - 0.3980
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateAug 27, 2026

About ODI Pharma AB

ODI Pharma AB (publ), a pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe. It offers dried flowers; and cosmetics products. ODI Pharma AB (publ) was founded in 2018 and is based in Stockholm, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2018
Employees 1
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 6OD

Financial Performance

In fiscal year 2025, ODI Pharma AB's revenue was 3.13 million, a decrease of -85.94% compared to the previous year's 22.29 million. Losses were -5.93 million, 944.5% more than in 2024.

Financial numbers in SEK Financial Statements

News

ODI Pharma AB Quarterly report: Q3 2026

ODI Pharma AB has published its Q3 2026 quarterly earnings report on May 28, 2026.

4 weeks ago - Filings

ODI Pharma AB Quarterly report: Q2 2026

ODI Pharma AB has published its Q2 2026 quarterly earnings report on February 26, 2026.

4 months ago - Filings

ODI Pharma AB Quarterly report: Q1 2026

ODI Pharma AB has published its Q1 2026 quarterly earnings report on November 27, 2025.

7 months ago - Filings

ODI Pharma AB Annual report: Q4 2025

ODI Pharma AB has published its Q4 2025 annual report on August 28, 2025.

10 months ago - Filings

ODI Pharma AB Quarterly report: Q4 2025

ODI Pharma AB has published its Q4 2025 quarterly earnings report on August 28, 2025.

10 months ago - Filings